Literature DB >> 8388509

Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus.

M J Gilbert1, S R Riddell, C R Li, P D Greenberg.   

Abstract

Responses of cytotoxic T-cells (Tc) to human cytomegalovirus (CMV) represent the predominant mechanism by which hosts resist CMV infection. The CMV major immediate-early protein (IE) is present throughout the virus replicative cycle. Studies were performed to determine whether Tc specific for IE effectively lyse CMV-infected targets and are thus capable of providing protective immunity against infection. After in vitro stimulation of peripheral blood mononuclear cells with CMV-infected autologous fibroblasts, Tc specific for IE were not readily detectable in CMV-reactive polyclonal Tc lines. However, after stimulation of peripheral blood mononuclear cells with cells selectively expressing IE, weak but detectable IE-specific Tc responses were observed. The frequency of IE-specific Tc clones derived from cultures stimulated with IE-expressing cells was 50 to 100 times lower than the frequency of Tc clones specific for other CMV proteins isolated from cultures stimulated with CMV-infected cells. All of the IE-specific Tc clones, which efficiently lysed targets selectively expressing IE, demonstrated minimal lysis of CMV-infected fibroblasts, despite abundant IE expression in these target cells. In contrast to these results with IE, other viral proteins were efficiently presented during all phases of CMV infection. These data suggest that CMV has evolved a unique mechanism for selectively limiting the presentation of the potentially immunogenic IE protein, which may preclude IE-specific Tc from providing protective immunity to CMV infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388509      PMCID: PMC237692     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  The specificity of recognition of a cytotoxic T lymphocyte epitope.

Authors:  S R Burrows; S J Rodda; A Suhrbier; H M Geysen; D J Moss
Journal:  Eur J Immunol       Date:  1992-01       Impact factor: 5.532

2.  Cytotoxic T-cell recognition of HIV proteins and peptides.

Authors:  D F Nixon; A J McMichael
Journal:  AIDS       Date:  1991-09       Impact factor: 4.177

3.  Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region.

Authors:  R M Stenberg; A S Depto; J Fortney; J A Nelson
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

4.  Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase.

Authors:  M Del Val; K Münch; M J Reddehase; U H Koszinowski
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

5.  The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells.

Authors:  S R Riddell; P D Greenberg
Journal:  J Immunol Methods       Date:  1990-04-17       Impact factor: 2.303

6.  Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression.

Authors:  S R Riddell; M Rabin; A P Geballe; W J Britt; P D Greenberg
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

7.  Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease.

Authors:  P Reusser; S R Riddell; J D Meyers; P D Greenberg
Journal:  Blood       Date:  1991-09-01       Impact factor: 22.113

8.  Generation of human cytomegalovirus-specific cytotoxic T-lymphocytes in a short-term culture.

Authors:  A Laubscher; H G Bluestein; S A Spector; N J Zvaifler
Journal:  J Immunol Methods       Date:  1988-05-25       Impact factor: 2.303

9.  An early event in murine cytomegalovirus replication inhibits presentation of cellular antigens to cytotoxic T lymphocytes.

Authors:  A E Campbell; J S Slater; V J Cavanaugh; R M Stenberg
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

10.  Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses.

Authors:  L K Borysiewicz; J K Hickling; S Graham; J Sinclair; M P Cranage; G L Smith; J G Sissons
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  33 in total

1.  Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors.

Authors:  G M Gillespie; M R Wills; V Appay; C O'Callaghan; M Murphy; N Smith; P Sissons; S Rowland-Jones; J I Bell; P A Moss
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Measurement of cytotoxic T lymphocyte activity of human cytomegalovirus seropositive individuals by a highly sensitive coupled luminescent method.

Authors:  Henry Ogbomo; Janina Geiler; Anke Leutz; Kristina von Kietzell; Martin Michaelis; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2009-10-08       Impact factor: 3.402

Review 3.  Uses of flow cytometry in virology.

Authors:  J J McSharry
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

4.  The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation.

Authors:  P J Lehner; J T Karttunen; G W Wilkinson; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

Review 5.  Herpesvirus-bacteria synergistic interaction in periodontitis.

Authors:  Casey Chen; Pinghui Feng; Jørgen Slots
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

6.  Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro.

Authors:  J L Davignon; P Castanié; J A Yorke; N Gautier; D Clément; C Davrinche
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

7.  Human cytomegalovirus pp71 stimulates major histocompatibility complex class i presentation of IE1-derived peptides at immediate early times of infection.

Authors:  Julia Hesse; Sabine Reyda; Stefan Tenzer; Katrin Besold; Nina Reuter; Steffi Krauter; Nicole Büscher; Thomas Stamminger; Bodo Plachter
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

8.  Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.

Authors:  K Ahn; A Angulo; P Ghazal; P A Peterson; Y Yang; K Früh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  Humoral immune response to human cytomegalovirus in patients undergoing percutaneous transluminal coronary angioplasty.

Authors:  A Tiran; R A Tio; E Oostenveld; M C Harmsen; B Tiran; P Den Heijer; S H Monnink; M M Wilders-Truschnig; T H The
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

10.  Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation.

Authors:  Karim Sacre; Stéphanie Nguyen; Claire Deback; Guislaine Carcelain; Jean-Paul Vernant; Véronique Leblond; Brigitte Autran; Nathalie Dhedin
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.